Jacqueline Lehmann‐Che

5.7k citations

89 papers · 3.4k · 1 hit paper · h-index 31

Impact in

Cancer Research top 1%
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Virology top 5%

Papers in

Cancer Research 37
- Cancer Genomics and Diagnostics 19
- Breast Cancer Treatment Studies 15
Oncology 32
- Cancer-related Molecular Pathways 13
- HER2/EGFR in Cancer Research 5

Co-authors: Charles‐Henri Lecellier (2 shared papers)Patrice Dunoyer (1 shared paper)Stéphanie Eyquem (1 shared paper)Khalil Arar (1 shared paper)Christophe Himber (1 shared paper)Olivier Voinnet (1 shared paper)Hugues de Thé (28 shared papers)Marc Espié (12 shared papers)
Journals: Cancer Research (6 papers)Blood (4 papers)Leukemia Research (3 papers)International Journal of Cancer (3 papers)British Journal of Cancer (3 papers)
Partner nations: France United States Belgium

In The Last Decade

Jacqueline Lehmann‐Che

82 papers receiving 3.4k citations

Jacqueline Lehmann‐Che's Hit Papers

align trajectories log scale

A Cellular MicroRNA Mediates Antiviral Defense in Human Cells 2005 · 738 citations

Peers

Countries citing papers authored by Jacqueline Lehmann‐Che

Since Specialization

Citations

This map shows the geographic impact of Jacqueline Lehmann‐Che's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline Lehmann‐Che with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline Lehmann‐Che more than expected).

Fields of papers citing papers by Jacqueline Lehmann‐Che

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline Lehmann‐Che. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline Lehmann‐Che. The network helps show where Jacqueline Lehmann‐Che may publish in the future.

Co-authors

The 25 scholars most cited alongside Jacqueline Lehmann‐Che, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jacqueline Lehmann‐Che Line = papers co-authored together Jacqueline Lehmann‐Che links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A Cellular MicroRNA Mediates Antiviral Defense in Human Cells Science ·Charles‐Henri Lecellier, Patrice Dunoyer, Khalil Arar, Jacqueline Lehmann‐Che, Stéphanie Eyquem, Christophe Himber, Ali Saïb, Olivier Voinnet Hit paper breakdown →	2005	738
2	Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer European Journal of Nuclear Medicine and Molecular Imaging ·David Groheux, Sylvie Giacchetti, Jean‐Luc Moretti, Raphaël Porcher, Marc Espié, Jacqueline Lehmann‐Che, Anne de Roquancourt, Anne‐Sophie Hamy, C. Cuvier, Laëtitia Vercellino, Elif Hindié	2010	312
3	p53 in breast cancer subtypes and new insights into response to chemotherapy The Breast ·Philippe Bertheau, Jacqueline Lehmann‐Che, Mariana Varna, Anne Dumay, Brigitte Poirot, Raphaël Porcher, Elisabeth Turpin, Louis‐François Plassa, Anne de Roquancourt, E. Bourstyn, Patricia de Crémoux, Anne Janin, Sylvie Giacchetti, Marc Espié, Hugues de Thé	2013	151
4	Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin−Cyclophosphamide Regimen PLoS Medicine ·Philippe Bertheau, Elisabeth Turpin, David S. Rickman, Marc Espié, Aurélien de Reyniès, Jean‐Paul Feugeas, Louis‐François Plassa, Hany Soliman, Mariana Varna, Anne de Roquancourt, Jacqueline Lehmann‐Che, Yves Beuzard, M. Marty, Jean-Louis Misset, Anne Janin, Hugues de Thé	2007	132
5	Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine Leukemia Research ·Cécile Bally, Lionel Adès, Aline Renneville, Marie Sébert, Virginie Éclache, Claude Preudhomme, Julien Mozziconacci, Hugues de Thé, Jacqueline Lehmann‐Che, Pierre Fenaux	2014	122
6	High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors Cancer Research ·Élodie Manié, Anne Vincent‐Salomon, Jacqueline Lehmann‐Che, Gaëlle Pierron, Elisabeth Turpin, Mathilde Warcoin, Nadège Gruel, Ingrid Lebigot, Xavier Sastre‐Garau, Rosette Lidereau, Audrey Remenieras, Jean Feunteun, Olivier Delattre, Hugues de Thé, Dominique Stoppa‐Lyonnet, Marc‐Henri Stern	2009	112
7	Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma Cancer Research ·Hana Janoušková, Anne Maglott, David Y. Léger, Catherine Bossert, Fanny Noulet, Éric Guérin, Dominique Guénot, Sophie Pinel, Pascal Chastagner, François Plénat, N. Entz-Werle, Jacqueline Lehmann‐Che, Julien Godet, Sophie Martin, Jan Teisinger, Monique Dontenwill	2012	104
8	Synergistic effects of PRIMA-1^Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia Haematologica ·Nabih Maslah, Norman Salomao, Louis Drevon, Emmanuelle Verger, Nicolas Partouche, Pierre Ly, Philippe Aubin, Nadia Naoui, Marie‐Hélène Schlageter, Cécile Bally, Elsa Miekoutima, Ramy Rahmé, Jacqueline Lehmann‐Che, Lionel Adès, Pierre Fenaux, Bruno Cassinat, Stéphane Giraudier	2019	100
9	Distinct tumor protein p53 mutants in breast cancer subgroups International Journal of Cancer ·Anne Dumay, Jean‐Paul Feugeas, Evelyne Wittmer, Jacqueline Lehmann‐Che, Philippe Bertheau, Marc Espié, Louis‐François Plassa, Paul Cottu, Michel Marty, Fabrice André, Christos Sotiriou, Lajos Pusztai, Hugues de Thé	2012	95
10	Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15 Breast Cancer Research ·Jacqueline Lehmann‐Che, Anne‐Sophie Hamy, Raphaël Porcher, Marc Barritault, Fatiha Bouhidel, Hanadi Habuellelah, Solenne Leman-Detours, Anne de Roquancourt, Laurence Cahen‐Doidy, E. Bourstyn, Patricia de Crémoux, C. de Bazelaire, M. Albiter, Sylvie Giacchetti, C. Cuvier, Anne Janin, Marc Espié, (unknown), (unknown)	2013	79
11	Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab British Journal of Cancer ·(unknown), M.E. Dujaric, Jacqueline Lehmann‐Che, Véronique Scott, O. Tembo, Bernard Asselain, J-Y Pierga, M. Marty, Patricia de Crémoux, F. Spyratos, Ivan Bièche	2013	76
12	Molecular and functional MDR1‐Pgp and MRPs expression in human glioblastoma multiforme cell lines International Journal of Cancer ·Xavier Declèves, Anne Fajac, Jacqueline Lehmann‐Che, M. Tardy, Claire Mercier, Ilse Hurbain, Jean Laplanche, Jean‐François Bernaudin, Jean‐Michel Scherrmann	2002	69
13	Chromatin Tethering of Incoming Foamy Virus by the Structural Gag Protein Traffic ·Joëlle Tobaly-Tapiero, Patricia Bittoun, Jacqueline Lehmann‐Che, Olivier Delelis, Marie‐Lou Giron, Hugues de Thé, Ali Saı̈b	2008	67
14	Hereditary Renal Cancer Syndromes: An Update of a Systematic Review European Urology ·Jérôme Verine, A. Pluvinage, Guilhem Bousquet, Jacqueline Lehmann‐Che, C. de Bazelaire, Nadem Soufir, P. Mongiat-Artus	2010	64
15	Foamy viruses — a world apart Current Opinion in Microbiology ·Olivier Delelis, Jacqueline Lehmann‐Che, Ali Saı̈b	2004	61
16	TP53 mutation‐correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53‐mutated breast cancers Molecular Oncology ·Balázs Győrffy, Giulia Bottai, Jacqueline Lehmann‐Che, Gÿorgý Kéri, László Őrfi, Takayuki Iwamoto, Christine Desmedt, Giampaolo Bianchini, Nicholas C. Turner, Hugues de Thé, Fabrice André, Christos Sotiriou, Gabriel N. Hortobagyi, Angelo Di Leo, Lajos Pusztai, Libero Santarpia	2014	60
17	Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review European Urology Focus ·Pierre‐Jean Lamy, Yves Allory, Anne‐Sophie Gauchez, Bernard Asselain, Philippe Beuzeboc, Patricia de Crémoux, Jacqueline Fontugne, Agnès Georges, Christophe Hennequin, Jacqueline Lehmann‐Che, Christophe Massard, Ingrid Millet, T. Murez, Marie‐Hélène Schlageter, Olivier Rouvière, Diana Kassab‐Chahmi, François Rozet, Jean‐Luc Descotes, Xavier Rébillard	2017	59
18	IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma Patients PLoS ONE ·Aymeric Amelot, Patricia de Crémoux, Véronique Quillien, Marc Polivka, Homa Adle‐Biassette, Jacqueline Lehmann‐Che, Laurence Françoise, Alain Carpentier, Bernard George, Emmanuel Mandonnet, Sébastien Froelich	2015	50
19	Estrogen receptor‐positive/human epidermal growth factor receptor 2‐negative breast tumors Cancer ·David Groheux, Mathieu Hatt, Elif Hindié, Sylvie Giacchetti, Patricia de Crémoux, Jacqueline Lehmann‐Che, Antoine Martineau, M. Marty, C. Cuvier, Catherine Cheze‐Le Rest, Anne de Roquancourt, Dimitris Visvikis, Marc Espié	2013	47
20	Distinct p53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers Clinical Cancer Research ·Charles Coutant, Roman Rouzier, Yuan Qi, Jacqueline Lehmann‐Che, Giampaolo Bianchini, Takayuki Iwamoto, Gabriel N. Hortobágyi, W. Fraser Symmans, Serge Uzan, Fabrice André, Hugues de Thé, Lajos Pusztai	2011	44

About Jacqueline Lehmann‐Che

Jacqueline Lehmann‐Che is a scholar working on Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 89 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (19 papers), Breast Cancer Treatment Studies (15 papers), Cancer-related Molecular Pathways (13 papers), Acute Myeloid Leukemia Research (8 papers), HIV Research and Treatment (6 papers), Medical Imaging Techniques and Applications (6 papers), HER2/EGFR in Cancer Research (5 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). The work is most often cited by research in Cancer Research (1.3k citations), Virology (206 citations), Oncology (1.0k citations), Molecular Biology (1.5k citations) and Hematology (240 citations). Jacqueline Lehmann‐Che has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Charles‐Henri Lecellier, Patrice Dunoyer, Stéphanie Eyquem, Khalil Arar, Christophe Himber, Olivier Voinnet, Hugues de Thé, Marc Espié, Anne de Roquancourt and Sylvie Giacchetti. Their work appears in journals such as Cancer Research, Blood, Leukemia Research, International Journal of Cancer and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Jacqueline Lehmann‐Che

Impact in

Papers in i

In The Last Decade

Jacqueline Lehmann‐Che

Jacqueline Lehmann‐Che's Hit Papers

Peers

Countries citing papers authored by Jacqueline Lehmann‐Che

Fields of papers citing papers by Jacqueline Lehmann‐Che

All Works

About Jacqueline Lehmann‐Che

Explore authors with similar magnitude of impact

Papers in